Bill Huffnagle brings over 29 years of Med Tech healthcare experience to CDx Diagnostics. Most recently, Bill was President of the $3B Reconstructive Division at Stryker Orthopaedics which included the global joint replacement business including hips, knees, robotics and Performance Solutions. He is a driven and innovative executive known for leading growth and capitalizing on market opportunities in complex and global environments. He has a proven record of creating clear goals and operational strategies to deliver strong returns, with an emphasis on market expansion, portfolio and product management.
During his tenure at Stryker, Mr. Huffnagle spearheaded the integration of Mako Surgical, the acquisition propelling Stryker to lead the world in orthopedic robotic-assisted surgery. Bill brings exceptional customer relationship skills, strategic thinking and drive for results to CDx. He has demonstrated the ability to build and develop strong teams and challenge the status quo to bring new, innovative approaches to drive business growth.
Bill has worked at all levels of the Med Tech industry starting in 1988 as a Sales Representative for Howmedica in the Orthopaedics reconstructive market. As VP/GM of Stryker’s Hip portfolio, he managed distribution and sales organizations, global R&D projects and marketing strategy.
Mark Rutenberg, PhD, MSEE, Founder and Chief Scientific Officer
Mark Rutenberg has devoted the last 20 years to the development, management and marketing of medical diagnostics, with particular concentration in application of advanced digital image processing techniques to anatomic pathology.
He pioneered the application to medicine of advanced image processing techniques originally developed for missile defense, and is the author of over a dozen patents in the areas of neural networks, image analysis and medical imaging. Mark has founded two companies in this area.
He led his first company, Neuromedical Systems, in what was described by Fortune magazine as “the most successful medical technology IPO of the 1990s.” When he left Neuromedical in June of 1997 it was projected to break even within the year with cash reserves in excess of $80M, and its technology for enhancing the accuracy of cervical Pap smears had been adopted by over 250 major US laboratories with another 50 laboratories on a waiting list for training. Mark is a recipient of the Ernst & Young Entrepreneur of the year award in the Life Sciences.
James Hutchinson, President and Chief Operating Officer
James H. Hutchinson has over 27 years of senior-level experience within the clinical and anatomic reference laboratory industry. He is an experienced, hands on senior laboratory executive with proven operational and project management skills. Mr. Hutchinson has extensive laboratory information technology development and management experience.
Most recently Mr. Hutchinson served as the Northeast Regional Manager for Sonic Healthcare USA., an international healthcare company where he was responsible for the highly profitable New Jersey operations.
As co-founder of Lifepoint Informatics in Midland Park, NJ, 1999, Mr. Hutchinson successfully designed, implemented and managed a feature-rich set of Internet-based solutions to deliver, present and archive laboratory test results and to place online laboratory test orders for clinical laboratories to physicians and to healthcare providers. Lifepoint Informatics is now one of the leading middleware providers in the laboratory industry.
In 2003 Mr. Hutchinson founded American Clinical Services where he led the design and implementation of the laboratory and led all financial and operational duties. ACS was successfully acquired in 2008 by Sonic Healthcare USA.
Mr. Hutchinson has held positions such as Senior IT Consultant at Quest Diagnostics and CIO at Clinical Diagnostics Services in Englewood, New Jersey. As a Consultant to Quest Diagnostics he spearheaded corporate integration of all information technology and other corporate functions.
Mr. Hutchinson obtained his Bachelors in Science in Computer Science Engineering from Tulane University.
Jimmy Cerveaux, Chief Financial Officer
Jimmy Cerveaux brings C-level executive experience with deep financial expertise acquired at blue chip companies and as an entrepreneur. He co-founded, led and sold Unicity Eldercare, a successful 150 employee healthcare company located in NY & NJ.
Mr. Cerveaux also worked for many years as an Auditor and a Mergers & Acquisitions Consultant at Ernst & Young, and as an equity analyst for a leading investment management firm in the Middle East. He is a graduate of Massachusetts Institute of Technology in Cambridge, MA.
Drore Eisen, MD, DDS, Co-Founder, Vice President and Medical Director
Drore Eisen is a dual trained dermatologist and dentist with expertise in diseases of the oral cavity. He received his B.A. from Columbia University, dental and medical degrees from the Medical College of Virginia and completed his dermatology training at the University of Michigan where he served as chief resident. He has authored 2 textbooks which have received accolades in many peer reviewed medical and dental publications, several chapters in textbooks and over 50 articles on oral and medical diseases including publications in The New England Journal of Medicine and The Lancet. Drore has been an invited and featured speaker at numerous major medical and dental conferences and a visiting lecturer at many universities, both nationally and internationally.
He is the recipient of the prestigious Harold O. Perry Lecture Award, Mayo Clinic. He has also served as a principal investigator or co-investigator in over 50 clinical trials with many large pharmaceutical companies and collaborated on oral cancer research projects with The National Cancer Institute.
Tom Bartel, Executive Vice President of Sales
Tom Bartel joined CDx Diagnostics in June 2015 with more than two decades of results-driven commercial diagnostics expertise and a demonstrated track record of building winning sales organizations, commercializing novel assays, and accelerating product adoption in key markets.
Tom served most recently as Sr. Sales Director, Eastern US, at Agendia, where he oversaw the profitable growth of genomic sequencing of breast cancer tumors. Prior to Agendia, Tom was the Chief Sales Officer for Genomind, a genetic testing start-up in the neuropsychiatric market. He has also served as North American Vice President of Sales for Ipsogen, a world-wide leader in blood cancer diagnostics, and Vice President at American Clinical Services (ACS), a start-up diagnostic testing company that he helped found.
During his ACS tenure, he delivered multiple successive years of annual sales growth, exceeding sales quotas and supporting the successful acquisition of ACS by Sonic Healthcare USA. Tom spent the first 11 years of his diagnostics career at Quest Diagnostics, where he served in various sales and marketing leadership roles including National Sales Director, Genomic Testing.
Tom holds a Bachelor of Science degree in industrial engineering from Rutgers University, College of Engineering.
Jerry Conway, Executive Vice President of Managed Care
Mr. Conway is a proven Managed Care Executive providing sales and marketing leadership for US commercial and government payer contracting sales, strategy and tactics for companies such as Metamark Genetic, Foundation Medicine, Genzyme Genetics and Corning Metpath. As Vice President of Payer Relations & Reimbursement at Foundation Medicine. Mr Conway obtained coverage and payment of novel Foundation Medicine products to access over 120 million lives covered by Medicare, United HealthCare, Priority Health and other regional payers.
Lori Bethon, Senior Vice President of Human Resources
Lori Bethon joined CDx Diagnostics in October of 2018 and brings over 25 years of human resources experience to the organization. Lori has specialized in various disciplines within the human resources field, including employee relations, compensation, benefits planning, organizational development and change management. She has held leadership positions in financial services, publishing, technology distribution and non-profit organizations. Lori has a bachelor’s of science degree in marketing from the State University of New York College at Plattsburgh and a master’s degree in organizational psychology from Columbia University.
Sandy Zinke, Vice President of Marketing & Business Development
Sandy Zinke joined CDx in June 2018 and brings over 20 years of Marketing and Business Development experience driving profitable growth for companies in the healthcare industry. Sandy spent 16 years with Boston Scientific, 14 of which were with the Endoscopy division. As Group Global Director of Marketing, Sandy managed a marketing team that was responsible for the development and implementation of the Marketing strategy for six product franchises that contributed over $600m in annual sales. Sandy has deep experience in product management, product development, market development, product launches and distribution partnerships. He has developed long-term relationships with physicians in many specialties and has worked across cultures in all regions of the world.
Immediately prior to CDx, Sandy was Executive Director of Product Marketing for Cynosure, a global leader in medical lasers that was ranked #30 on Fortune’s 2016 list of the 100 Fastest Growing Companies in the World.
Sandy has a BA in Political Science from Amherst College and an MBA from Harvard Business School.
Robert Tjon, Vice President of Engineering
Robert received an undergraduate degree in Physics from Fordham University, a Bachelor’s and Master’s Degree in Electrical Engineering from Columbia University, in a relative short time span of 6 years. In 1988, he worked as a Research Associate with Dr Leopold Koss at Montefiore Hospital to develop classifiers to recognize cancer cells in voided urine using image processing and multivariable statistical analysis. In 1990, he joined Neuromedical Systems, a startup company, to develop a premier application to sort cancer cells in cervical pap smears using neural networks. He was instrumental in submitting a PMA to the FDA as a medical device. Its success lead to a successful IPO of 30 million dollars.
For a year, he worked for TriPath Imaging to develop a virtual microscope, a universal plug-in to work with a multitude of microscopes. Subsequently, he worked for Physiome Sciences to develop computerized physiological models of human and animal cells, to understand and accelerate the development of pharmaceutical drugs. Starting in 2003, at OralCDx, Robert developed the next generation high resolution scanner system and developed specific technologies to further increase both the image quality and overall accuracy and sensitivity of the system to analyze thick brush biopsy samples.
Frank Fromowitz, MD, Laboratory Director
Dr. Frank Fromowitz has over 35 years of experience as an anatomic pathologist in academic, community hospital, and private laboratory settings, including work in the pathology of the gastrointestinal tract. He trained in Anatomic Pathology at Yale University School of Medicine, held full time academic appointments at the state universities of New York and New Jersey, and published over 50 articles in peer reviewed journals, including the New England Journal of Medicine and Cancer. Dr. Fromowitz has worked with such noted pathologists as Drs. Charles Carrington, Leo Koss, and Lauren Ackerman, has taught medical students and residents at several institutions, and was nominated for the Golden Apple Teaching Award at the New Jersey Medical School.